Contracts › 75F40124C00124
75F40124C00124: Biofab Foundry: a Scalable, Closed, Automated, Medical Product Manufacturing System
Awarded to Advanced Regenerative Manufacturing Institute Inc by Food and Drug Administration (FDA).
$2.2Mobligated
$2.2Mpotential value
29 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40124C00124 |
|---|---|
| Awardee | Advanced Regenerative Manufacturing Institute Inc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541720 Research and Development in the Social Sciences and Humanities |
| PSC | AJ11 General Science and Technology R&D Services; General Science and Technology; Basic Research |
| Place of performance | NH |
| Offers received | 1 |
| Period of performance | 19 September 2024 to 29 September 2027 |
| Potential end | 29 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541720 contracts · All expiring contracts · USASpending record